COGT - CIK 0001622229
Cogent Biosciences, Inc. (COGT) reported revenue of $7.87M for fiscal year 2020, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2020 | $7.87M | -65.0% |
| FY 2019 | $22.50M | +131.1% |
| FY 2018 | $9.73M | +16.4% |
| FY 2017 | $8.36M | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.